Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Huangbai liquid for diabetic foot infection with drug‑resistant bacteria
ChiCTR2000041443Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of compound phellodendron liquid in diabetic foot ulcer (DFU), diabetic foot infection (DFI) and bacterial disease (2 arms), sponsored by Beijing University of Chinese Medicine. Primary endpoints: Infection control rate and Time to infection control. Started Dec 2019; status: recruiting.
02
Drugs
compound phellodendron liquid
03
Conditions
diabetic foot ulcer (DFU)diabetic foot infection (DFI)bacterial disease
Beyond the preview
Go deeper on ChiCTR2000041443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041443.